GPAM
Basic information
Region (hg38): 10:112149865-112215377
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPAM gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 31 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 1 | 3 |
Variants in GPAM
This is a list of pathogenic ClinVar variants found in the GPAM region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-112153638-A-C | not specified | Uncertain significance (May 23, 2023) | ||
10-112155893-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
10-112155897-T-C | not specified | Likely benign (Mar 31, 2022) | ||
10-112155905-T-C | not specified | Uncertain significance (Feb 10, 2023) | ||
10-112157260-A-G | not specified | Uncertain significance (Mar 18, 2024) | ||
10-112158342-G-T | not specified | Uncertain significance (Nov 17, 2023) | ||
10-112159957-G-A | not specified | Uncertain significance (May 27, 2022) | ||
10-112159964-G-C | not specified | Uncertain significance (May 17, 2023) | ||
10-112160630-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
10-112160694-T-C | not specified | Uncertain significance (Oct 14, 2023) | ||
10-112160706-C-G | not specified | Uncertain significance (Dec 07, 2021) | ||
10-112160814-G-C | not specified | Uncertain significance (Nov 10, 2021) | ||
10-112160820-C-T | not specified | Uncertain significance (Jun 26, 2023) | ||
10-112160864-A-G | not specified | Uncertain significance (Dec 14, 2023) | ||
10-112161671-C-G | not specified | Uncertain significance (Mar 02, 2023) | ||
10-112163799-T-C | not specified | Uncertain significance (Aug 02, 2021) | ||
10-112164561-A-G | not specified | Uncertain significance (Aug 01, 2022) | ||
10-112164573-G-A | Benign (Jul 23, 2018) | |||
10-112164589-G-T | not specified | Uncertain significance (Dec 27, 2023) | ||
10-112164616-G-GA | Benign (Jul 23, 2018) | |||
10-112166426-A-G | Benign (Jul 23, 2018) | |||
10-112166474-T-A | not specified | Uncertain significance (Mar 20, 2024) | ||
10-112168352-T-C | not specified | Uncertain significance (Mar 31, 2023) | ||
10-112168440-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
10-112168443-A-G | not specified | Uncertain significance (Jul 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPAM | protein_coding | protein_coding | ENST00000348367 | 20 | 65512 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.24e-9 | 1.00 | 125699 | 0 | 49 | 125748 | 0.000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.37 | 359 | 440 | 0.816 | 0.0000228 | 5425 |
Missense in Polyphen | 80 | 139.29 | 0.57434 | 1766 | ||
Synonymous | -1.37 | 184 | 162 | 1.14 | 0.00000828 | 1595 |
Loss of Function | 3.36 | 23 | 48.1 | 0.478 | 0.00000277 | 531 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000601 | 0.000600 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.000462 | 0.000462 |
European (Non-Finnish) | 0.000106 | 0.000105 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Esterifies acyl-group from acyl-ACP to the sn-1 position of glycerol-3-phosphate, an essential step in glycerolipid biosynthesis. {ECO:0000250|UniProtKB:P97564, ECO:0000269|PubMed:18238778}.;
- Pathway
- Glycerolipid metabolism - Homo sapiens (human);Glycerophospholipid metabolism - Homo sapiens (human);Metformin Pathway, Pharmacodynamic;Familial lipoprotein lipase deficiency;Glycerolipid Metabolism;Glycerol Kinase Deficiency;Phospholipid Biosynthesis;D-glyceric acidura;Sterol Regulatory Element-Binding Proteins (SREBP) signalling;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Activation of gene expression by SREBF (SREBP);Estrogen Receptor Pathway;Nuclear Receptors Meta-Pathway;Triacylglyceride Synthesis;Transcriptional regulation by RUNX1;Signal Transduction;Gene expression (Transcription);Generic Transcription Pathway;Metabolism of lipids;RNA Polymerase II Transcription;Regulation of cholesterol biosynthesis by SREBP (SREBF);Metabolism;CDP-diacylglycerol biosynthesis;Metabolism of steroids;Glycerophospholipid metabolism;Triglyceride biosynthesis;Triglyceride metabolism;triacylglycerol biosynthesis;Signaling by Nuclear Receptors;Glycerophospholipid biosynthesis;Phospholipid metabolism;Estrogen-dependent gene expression;Activation of gene expression by SREBF (SREBP);Synthesis of PA;RUNX1 regulates estrogen receptor mediated transcription;ESR-mediated signaling;Transcriptional regulation by RUNX1;Validated targets of C-MYC transcriptional activation
(Consensus)
Recessive Scores
- pRec
- 0.375
Intolerance Scores
- loftool
- 0.581
- rvis_EVS
- -0.24
- rvis_percentile_EVS
- 36.23
Haploinsufficiency Scores
- pHI
- 0.222
- hipred
- Y
- hipred_score
- 0.524
- ghis
- 0.437
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.969
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpam
- Phenotype
- liver/biliary system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- glycerol-3-phosphate metabolic process;fatty acid metabolic process;acyl-CoA metabolic process;phosphatidic acid biosynthetic process;phospholipid biosynthetic process;response to glucose;CDP-diacylglycerol biosynthetic process;triglyceride biosynthetic process;regulation of intracellular estrogen receptor signaling pathway;positive regulation of multicellular organism growth;positive regulation of activated T cell proliferation;regulation of cholesterol biosynthetic process;regulation of cytokine secretion;defense response to virus;fatty acid homeostasis;phospholipid homeostasis;negative regulation of activation-induced cell death of T cells;interleukin-2 secretion
- Cellular component
- mitochondrial outer membrane;plasma membrane;integral component of membrane;mitochondrial membrane
- Molecular function
- glycerol-3-phosphate O-acyltransferase activity;sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity